Investigations of New Pyridazinone Derivatives for the Synthesis of Potent Analgesic and Anti‐Inflammatory Compounds with Cyclooxygenase Inhibitory Activity
Authors:
- Serdar ÜnlüSÜSerdar Ünlü
- Erden BanogluEBErden Banoglu
- Esra KüpeliEKEsra Küpeli
- Erdem YeşiladaEYErdem Yeşilada
- M. Fethi ŞahinMŞM. Fethi Şahin
- 29 September 2003
- journal article
- research article
- Published by Wiley in Archiv der Pharmazie
- Vol. 336 (9) , 406-412
Abstract
In this study we describe the synthesis of two novel 4‐phenyl‐and 4‐(2‐chlorophenyl)‐6‐(5‐chloro‐2‐oxo‐3H‐benzoxazol‐7‐yl)‐3(2H)‐pyridazinone derivatives (compounds 8a and b) and their testing as inhibitors of cyclooxygenases (COX‐1 and COX‐2). Both compounds inhibited COX‐1 (by 59 % and 61 % for compounds 8a and 8b respectively and COX‐2 (by 37 % and 28 % for compounds 8a and 8b spectively) at a concentration of 10 μM. Furthermore, we tested the analgesic and anti‐inflammatory activities of the synthesized compounds in vivo by using the pbenzoquinone‐induced writhing test and the carrageenan‐induced hind paw edema model, respectively. Compounds 8a and 8b showed potent analgesic and anti‐inflammatory activities without causing gastric lesions in the tested animals.Keywords
This publication has 23 references indexed in Scilit:
- Studies on Novel 7‐Acyl‐5‐chloro‐2‐oxo‐3H‐benzoxazole Derivatives as Potential Analgesic and Anti‐Inflammatory AgentsArchiv der Pharmazie, 2003
- Amide Derivatives of [5-Chloro-6-(2-chloro/fluorobenzoyl)-2-benzoxazolinone-3-yl]acetic Acids as Potential Analgesic and Anti-Inflammatory CompoundsArchiv der Pharmazie, 2003
- Synthesis of New Pyridazinones Substituted by 4-Arylpiperazin-1-yl-carbonylalkyl Moieties and their Analgesic Properties in MicePharmacy and Pharmacology Communications, 2000
- Synthesis and biological activity of annulated pyrazoles as selective COX-2 inhibitors. I.Archives of Pharmacal Research, 1999
- Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2Rheumatology, 1999
- The discovery of rofecoxib, [MK 966, VIOXX®, 4-(4′-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2 inhibitorBioorganic & Medicinal Chemistry Letters, 1999
- COX-2 inhibitorsThe Lancet, 1999
- Anti-nociceptive and anti-inflammatory activity of some (2-benzoxazolone-3-yl and 2-benzothiazolone-3-yl) acetic acid derivativesIl Farmaco, 1998
- Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX‐2 inhibitorBritish Journal of Pharmacology, 1997
- Synthesis and Trazodone-like Analgesic Activity of 4-Phenyl-6-aryl-2-(3-(4-arylpiperazin-1-yl)propyl)pyridazin-3-ones.Chemical and Pharmaceutical Bulletin, 1996